Bo Jesper Hansen
Chairman at Innoventa Medica ApS
Profile
Bo Jesper Hansen founded Scandinavian Medical Research.
Dr. Hansen also currently works at Innoventa Medica ApS, as Chairman, Reapplix A, as Director, MipSalus ApS, as Director, CMC Sweden AB, as Director, Wellington Partners GmbH, as Venture Partner, and Amylon Therapeutics BV, as Member-Supervisory Board.
Dr. Hansen also formerly worked at Swedish Orphan International Holding AB, as President & Chief Executive Officer from 2009 to 2010, Swedish Orphan Biovitrum International AB, as President, Chief Executive Officer & Director from 1993 to 2010, 2941881 Canada, Inc., as Chairman, Karo Healthcare AB, as Chairman, Topotarget A, as Executive Chairman from 2013 to 2014, Biovitrum AB, as Chairman in 2010, Karolinska Development AB (Private Equity), as Chairman from 2011 to 2017, Ablynx NV, as Chairman in 2018, Orphazyme A, as Chairman from 2022 to 2023, Swedish Orphan Biovitrum AB, as Chairman from 2023 to 2024, Swedish Orphan Biovitrum AB, as Chairman from 2010 to 2016, Karolinska Development AB, as Chairman from 2013 to 2017, CMC Contrast AB, as Director, Hyperion Therapeutics, Inc., as Independent Non-Executive Director from 2011 to 2015, Rebus Holdings, Inc., as Independent Director from 2011 to 2017, Gambro AB, as Director from 2010 to 2012, Incentive AB, as Director, Valerio Therapeutics SA, as Director, Newron Pharmaceuticals SpA, as Independent Non-Executive Director from 2013 to 2018, ACE BioSciences ApS, as Director, Zymenex A, as Director from 2008 to 2013, Novagali Pharma SA, as Director-Supervisory Board from 2010 to 2011, Azanta A, as Non-Executive Director from 2015 to 2020, Ascelia Pharma AB, as Independent Director, Yamanouchi Nordic, as Medical Advisor, Synthélabo Scandinavia A, as Medical Advisor, and Pfizer ApS, as Medical Advisor.
Dr. Hansen received his doctorate degree in 1978 from the University of Copenhagen.
Bo Jesper Hansen active positions
Companies | Position | Start |
---|---|---|
MipSalus ApS
MipSalus ApS Miscellaneous Commercial ServicesCommercial Services MipSalus ApS is a Danish company that conducts research and experimental development in the field of natural sciences and engineering. | Director/Board Member | 2011-03-14 |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Private Equity Investor | - |
Innoventa Medica ApS | Chairman | - |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Director/Board Member | - |
CMC Sweden AB | Director/Board Member | - |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Director/Board Member | - |
Former positions of Bo Jesper Hansen
Companies | Position | End |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Chairman | 2024-01-04 |
ORPHAZYME A/S | Chairman | 2023-05-16 |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Director/Board Member | 2020-03-23 |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Bo Jesper Hansen
University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 8 |
---|---|
REBUS HOLDINGS, INC. | Health Technology |
KARO PHARMA AB (PUBL) | Health Technology |
VALERIO THERAPEUTICS | Health Technology |
NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
ORPHAZYME A/S | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
ASCELIA PHARMA AB | Health Technology |
Private companies | 25 |
---|---|
CMC Contrast AB
CMC Contrast AB Pharmaceuticals: MajorHealth Technology CMC Contrast AB develops magnetic resonance contrast agents for patients suffering with tumors. Its product CMC 001 is a Manganese containing orally administered magnetic resonance imaging (MRI) contrast medium for enhancement of the liver, bile ducts and gastrointestinal tract. The company was founded by Henrik S. Thomsen in 2000 and is headquartered in Malmo, Sweden. | Health Technology |
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
2941881 Canada, Inc.
2941881 Canada, Inc. Medical SpecialtiesHealth Technology 2941881 Canada, Inc. manufactures and supplies pelvic health and gastrointestinal equipment and consumables. The company was founded by Raymond George Yves Laborie in 1967 and is headquartered in Mississauga, Canada. | Health Technology |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
Incentive AB | Finance |
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Finance |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Health Technology |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
Yamanouchi Nordic | |
Scandinavian Medical Research | |
Synthélabo Scandinavia A/S | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Health Technology |
Swedish Orphan Biovitrum International AB
Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Health Technology |
Pfizer ApS
Pfizer ApS Medical DistributorsDistribution Services Part of Pfizer Inc., Pfizer ApS is a Danish bio-pharmaceutical company. The private company is based in Ballerup, Denmark. Pfizer is one of the world's leading bio-pharmaceutical companies. | Distribution Services |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Distribution Services |
MipSalus ApS
MipSalus ApS Miscellaneous Commercial ServicesCommercial Services MipSalus ApS is a Danish company that conducts research and experimental development in the field of natural sciences and engineering. | Commercial Services |
Innoventa Medica ApS | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
CMC Sweden AB |
- Stock Market
- Insiders
- Bo Jesper Hansen